A Two-Stage Approach to the Study of Potato Disease Severity Classification
Xu, Yanlei, Gao, Zhiyuan, Wang, Jingli, Zhou, Yang, Li, Jian, Meng, Xianzhang
Published in Agriculture (Basel) (01.02.2024)
Published in Agriculture (Basel) (01.02.2024)
Get full text
Journal Article
The Discrete Taxonomic Classification of Soils Subjected to Diverse Treatment Modalities and Varied Fertility Grades Utilizing Machine Olfaction
Liu, Shuyan, Chen, Xuegeng, Huang, Dongyan, Wang, Jingli, Jiang, Xinming, Meng, Xianzhang, Gao, Xiaomei
Published in Agriculture (Basel) (01.02.2024)
Published in Agriculture (Basel) (01.02.2024)
Get full text
Journal Article
p-Moment stability of stochastic differential equations with jumps
Wu, Shujin, Han, Dong, Meng, Xianzhang
Published in Applied mathematics and computation (05.05.2004)
Published in Applied mathematics and computation (05.05.2004)
Get full text
Journal Article
Phase 1, randomized, open-label, single-dose, crossover study to evaluate the bioequivalence of four formulations of oral rivoceranib tablets in healthy subjects
Weyer, Janelle, Meng, Xianzhang, Finis, Lynda, Strickland, Bill, Park, CheolHee, Jang, Seong
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Patient-reported outcomes (PROs) <65 or ≥ 65 years old (yo) from CARES-310 camrelizumab + rivoceranib vs sorafenib as first-line treatment for patients with unresectable hepatocellular carcinoma (uHCC)
Chan, Stephen Lam, Kaseb, Ahmed Omar, Shi, Wei, Alexander, Laura, Meng, Xianzhang, Park, CheolHee, Ryan, Kristin, Vogel, Arndt
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Impact of baseline liver function on survival outcomes in patients with unresectable hepatocellular carcinoma (uHCC) treated with camrelizumab + rivoceranib vs sorafenib: A post hoc analysis of study CARES-310
Vogel, Arndt, Cheng, Ann-Lii, Shi, Wei, Jang, Seong, Alexander, Laura, Meng, Xianzhang, Raphael, Natalia, Chan, Stephen Lam
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Stability and bifurcation in a non-kolmogorov type prey-predator system with time delay
Meng, Xianzhang, Han, Dong, Song, Yongli
Published in Mathematical and computer modelling (01.06.2005)
Published in Mathematical and computer modelling (01.06.2005)
Get full text
Journal Article
Role of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte-ratio (PLR) in unresectable hepatocellular carcinoma (uHCC): Subgroup analysis of patients treated with camrelizumab (cam) + rivoceranib (rivo) in the CARES-310 trial
Burgoyne, Adam, Kaseb, Ahmed Omar, Shi, Wei, Alexander, Laura, Meng, Xianzhang, Ryan, Kristin, Galloway, Chris, Neubach, Will, Vogel, Arndt, Chan, Stephen Lam
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma
Hanna, Glenn J, Ahn, Myung-Ju, Muzaffar, Jameel, Keam, Bhumsuk, Bowles, Daniel W, Wong, Deborah J, Ho, Alan L, Kim, Sung-Bae, Worden, Francis, Yun, Tak, Meng, Xianzhang, Van Tornout, Jan M, Conlan, Maureen G, Kang, Hyunseok
Published in Clinical cancer research (14.11.2023)
Published in Clinical cancer research (14.11.2023)
Get full text
Journal Article
Updated results from a phase 2 study of the oral vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor rivoceranib for recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC)
Kang, Hyunseok, Ahn, Myung-Ju, Keam, Bhumsuk, Bowles, Daniel W., Wong, Deborah J.L., Ho, Alan Loh, Kim, Sung-Bae, Worden, Francis P., Yun, Tak, Jang, Seong, Meng, Xianzhang, Hanna, Glenn J.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary analysis report
Kishnani, Priya S., Kronn, David, Brassier, Anaïs, Broomfield, Alexander, Davison, James, Hahn, Si Houn, Kumada, Satoko, Labarthe, François, Ohki, Hirotaka, Pichard, Samia, Prakalapakorn, S. Grace, Haack, Kristina An, Kittner, Barbara, Meng, Xianzhang, Sparks, Susan, Wilson, Catherine, Zaher, Atef, Chien, Yin-Hsiu
Published in Genetics in medicine (01.02.2023)
Published in Genetics in medicine (01.02.2023)
Get full text
Journal Article
Abstract CT131: Effect of rivoceranib administered as 200 mg once daily on the pharmacokinetics of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 substrates
Jang, Seong, Wei, Xiaohui (Tracey), Meng, Xianzhang, Reitano, Joseph, Urity, Vinoo, Park, Cheol Hee, Strickland, Bill, Lee, Grace, Nguyen, David
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Mini-COMET study: Safety, biomarker, and efficacy data after avalglucosidase alfa dosing for ≥ 97 weeks in participants with infantile-onset pompe disease (IOPD) previously treated with alglucosidase alfa who had demonstrated clinical decline
Kronn, David, Davison, James, Brassier, Anaïs, Broomfield, Alexander, Hahn, Si Houn, Kumada, Satoko, Labarthe, François, Ohki, Hirotaka, Prakalapakorn, S. Grace, Haack, Kristina An, Meng, Xianzhang, Sparks, Susan, Tammireddy, Swathi, Wilson, Catherine, Zaher, Atef, Zhou, Tianyue, Chien, Yin-Hsiu, Kishnani, Priya S.
Published in Molecular genetics and metabolism (01.02.2022)
Published in Molecular genetics and metabolism (01.02.2022)
Get full text
Journal Article
Mini-COMET: effects of avalglucosidase alfa on ptosis in participants with infantile-onset Pompe disease previously treated with alglucosidase alfa
Prakalapakorn, S. Grace, Davison, James, Broomfield, Alexander, Kronn, David, Labarthe, François, Brassier, Anaïs, Hahn, Si Houn, Kumada, Satoko, Ohki, Hirotaka, Pichard, Samia, Haack, Kristina An, Johnson, Judith, Meng, Xianzhang, Chien, Yin-Hsiu, Kishnani, Priya
Published in Molecular genetics and metabolism (01.04.2021)
Published in Molecular genetics and metabolism (01.04.2021)
Get full text
Journal Article
Mini-COMET: Individual-level treatment responses in infantile-onset Pompe disease participants receiving avalglucosidase alfa or alglucosidase alfa who previously received alglucosidase alfa
Kishnani, Priya, Broomfield, Alexander, Davison, James, Labarthe, François, Brassier, Anaïs, Hahn, Si Houn, Kumada, Satoko, Ohki, Hirotaka, Pichard, Samia, Haack, Kristina An, Johnson, Judith, Meng, Xianzhang, Chien, Yin-Hsiu, Kronn, David
Published in Molecular genetics and metabolism (01.04.2021)
Published in Molecular genetics and metabolism (01.04.2021)
Get full text
Journal Article
eP211 - Mini-COMET: effects of avalglucosidase alfa on ptosis in participants with infantile-onset Pompe disease previously treated with alglucosidase alfa
Prakalapakorn, S. Grace, Davison, James, Broomfield, Alexander, Kronn, David, Labarthe, François, Brassier, Anaïs, Hahn, Si Houn, Kumada, Satoko, Ohki, Hirotaka, Pichard, Samia, Haack, Kristina An, Johnson, Judith, Meng, Xianzhang, Chien, Yin-Hsiu, Kishnani, Priya
Published in Molecular genetics and metabolism (01.04.2021)
Published in Molecular genetics and metabolism (01.04.2021)
Get full text
Journal Article
eP110 - Mini-COMET: Individual-level treatment responses in infantile-onset Pompe disease participants receiving avalglucosidase alfa or alglucosidase alfa who previously received alglucosidase alfa
Kishnani, Priya, Broomfield, Alexander, Davison, James, Labarthe, François, Brassier, Anaïs, Hahn, Si Houn, Kumada, Satoko, Ohki, Hirotaka, Pichard, Samia, Haack, Kristina An, Johnson, Judith, Meng, Xianzhang, Chien, Yin-Hsiu, Kronn, David
Published in Molecular genetics and metabolism (01.04.2021)
Published in Molecular genetics and metabolism (01.04.2021)
Get full text
Journal Article
Abstract CT273: Evaluation of the effect of rivoceranib on the pharmacokinetics of cytochrome P450 enzyme substrates in healthy volunteers
Weyer, Janelle, Meng, Xianzhang, Lee, Jennifer, Reitano, Joseph, Urity, Vinoo, Park, Cheol-Hee, Strickland, Bill, Van Tornout, Jan, Jang, Seong
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
Mini-COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfa
Davison, James, Brassier, Anaïs, Broomfield, Alexander, Chien, Yin-Hsiu, Hahn, Si Houn, Kronn, David, Kumada, Satoko, Labarthe, François, Ohki, Hirotaka, Pichard, Samia, Prakalapakorn, S. Grace, Haack, Kristina An, Johnson, Judith, Meng, Xianzhang
Published in Molecular genetics and metabolism (01.02.2021)
Published in Molecular genetics and metabolism (01.02.2021)
Get full text
Journal Article